Psychoneuroendocrinology
Volume 33, Issue 6 , Pages 693-710 , July 2008

The link between childhood trauma and depression: Insights from HPA axis studies in humans

Received 5 July 2007 ,Revised 13 February 2008 ,Accepted 14 March 2008.

References 

  1. Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, Murad H, et al. Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol. Psychiatry. 1999;4:163–172
  2. Akiskal HS, McKinney WT. Depressive disorders: toward a unified hypothesis. Science. 1973;182:20–29
  3. American Psychiatric Assocation . Diagnostic and Statistical Manual of Mental Disorders. forth ed. Washington: American Psychiatric Association; 1994;
  4. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol. Psychiatry. 1999;4:182–188
  5. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 1999;160:1–12
  6. Bánki CM, Bissette G, Arato M, O’Connor L, Nemeroff CB. Cerebrospinal fluid corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry. 1987;144:873–877
  7. Barr CS, Newman TK, Schwandt M, Shannon C, Dvoskin RL, Lindell SG, et al. Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc. Natl. Acad. Sci. USA. 2004;101:12358–12363
  8. Bernet CZ, Stein MB. Relationship of childhood maltreatment to the onset and course of major depression in adulthood. Depress Anxiety. 1999;9:169–174
  9. Bethea CL, Mirkes SJ, Su A, Michelson D. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology. 2002;27:431–445
  10. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 2004;36:1319–1325
  11. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology. 2003;28:1328–1335
  12. Bradley RG, Binder EB, Epstein M, Tang Y, Nair H, Liu W, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch. Gen. Psychiatry. 2008;65:190–200
  13. Bremner JD, Randall P, Vermetten E, Staib L, Bronen RA, Mazure C, et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse—a preliminary report. Biol. Psychiatry. 1997;41:23–32
  14. Bremner JD, Southwick SM, Johnson DR, Yehuda R, Charney DS. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am. J. Psychiatry. 1993;150:235–239
  15. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am. J. Psychiatry. 2000;157:115–118
  16. Brown GW, Moran P. Clinical and psychosocial origins of chronic depressive episodes. I: A community survey. Br. J. Psychiatry. 1994;165:447–456
  17. Brunson KL, Eghbal-Ahmadi M, Bender R, Chen Y, Baram TZ. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc. Natl. Acad. Sci. USA. 2001;98:8856–8861
  18. Burgess LH, Handa RJ. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology. 1992;131:1261–1269
  19. Carpenter LL, Tyrka AR, McDougle CJ, Malison RT, Owens MJ, Nemeroff CB, et al. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology. 2004;29:777–784
  20. Carpenter LL, Carvalho JP, Tyrka AR, Wier LM, Mello AF, Mello MF, et al. Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biol. Psychiatry. 2007;62:1080–1087
  21. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389
  22. Centeno ML, Reddy AP, Smith LJ, Sanchez RL, Henderson JA, Salli NC, et al. Serotonin in microdialysate from the mediobasal hypothalamus increases after progesterone administration to estrogen primed macaques. Eur. J. Pharmacol. 2007;555:67–75
  23. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF. Adverse childhood experiences and the risk of depressive disorders in adulthood. J. Affect Disord. 2004;82:217–225
  24. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 1986;6:2908–2914
  25. Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, Gorman JM, et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. USA. 1996;93:1619–1623
  26. Craig AD. Interoception: the sense of the physiological condition of the body. Curr. Opin. Neurobiol. 2003;13:500–505
  27. Creed F, Guthrie E, Ratcliffe J, Fernandes L, Rigby C, Tomenson B, et al. Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome. Psychosom. Med. 2005;67:490–499
  28. De Bellis MD, Keshavan MS, Clark DB, Casey BJ, Giedd JN, Boring AM, et al. A.E. Bennett research award. Developmental traumatology. Part II: brain development. Biol. Psychiatry. 1999;45:1271–1284
  29. Dettling AC, Feldon J, Pryce CR. Early deprivation and behavioral and physiological responses to social separation/novelty in the marmoset. Pharmacol. Biochem. Behav. 2002;73:259–269
  30. Dong M, Giles WH, Felitti VJ, Dube SR, Williams JE, Chapman DP, et al. Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation. 2004;110:1761–1766
  31. Dougherty LR, Klein DN, Davila J. A growth curve analysis of the course of dysthymic disorder: the effects of chronic stress and moderation by adverse parent-child relationships and family history. J. Consult. Clin. Psychol. 2004;72:1012–1021
  32. Driessen M, Herrmann J, Stahl K, Zwaan M, Meier S, Hill A, et al. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch. Gen. Psychiatry. 2000;57:1115–1122
  33. Drossman DA, Leserman J, Nachman G, Li ZM, Gluck H, Toomey TC, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann. Intern. Med. 1990;113:828–833
  34. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, et al. Cognitive–behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19–31
  35. Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF, Giles WH. Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA. 2001;286:3089–3096
  36. Edwards VJ, Holden GW, Felitti VJ, Anda RF. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am. J. Psychiatry. 2003;160:1453–1460
  37. Feldman S, Conforti N, Weidenfeld J. Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. Neurosci. Biobehav. Rev. 1995;19:235–240
  38. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am. J. Prev. Med. 1998;14:245–258
  39. Francis DD, Champagne FC, Meaney MJ. Variations in maternal behaviour are associated with differences in oxytocin receptor levels in the rat. J. Neuroendocrinol. 2000;12:1145–1148
  40. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jager M, et al. Hippocampal changes in patients with a first episode of major depression. Am. J. Psychiatry. 2002;159:1112–1118
  41. Fuchs E, Gould E. Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications. Eur. J. Neurosci. 2000;12:2211–2214
  42. Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom. Med. 2005;67:S26–S28
  43. Gladstone GL, Parker GB, Mitchell PB, Malhi GS, Wilhelm K, Austin MP. Implications of childhood trauma for depressed women: an analysis of pathways from childhood sexual abuse to deliberate self-harm and revictimization. Am. J. Psychiatry. 2004;161:1417–1425
  44. Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am. J. Psychiatry. 1984;141:619–627
  45. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch. Gen. Psychiatry. 2004;61:34–41
  46. Hammen C, Davila J, Brown G, Ellicott A, Gitlin M. Psychiatric history and stress: Predictors of severity of unipolar depression. J. Abnorm. Psychol. 1992;100:555–561
  47. Hammen C, Henry R, Daley SE. Depression and sensitization to stressors among young women as a function of childhood adversity. J. Consult. Clin. Psychol. 2000;68:782–787
  48. Hardt J, Rutter M. Validity of adult retrospective reports of adverse childhood experiences: review of the evidence. J. Child Psychol. Psychiatry. 2004;45:260–273
  49. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400–403
  50. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, et al. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry. 2005;62:146–152
  51. Hartline KM, Owens MJ, Nemeroff CB. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans. Ann. NY Acad. Sci. 1996;780:96–105
  52. Hayden EP, Klein DN. Outcome of dysthymic disorder at 5-year follow-up: the effect of familial psychopathology, early adversity, personality, comorbidity, and chronic stress. Am. J. Psychiatry. 2001;158:1864–1870
  53. Heim C, Ehlert U. Pharmakologische Provokationstests zur Einschätzung der neuroendokrinen Funktion. In:  Kirschbaum C,  Hellhammer DH editor. Enzyklopädie der Psychologie (Serie I, Band 3). Psychoendokrinologie und Psychoimmunologie. Göttingen: Hogrefe; 1999;p. 307–359
  54. Heim C, Ehlert U, Hanker JP, Hellhammer DH. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic–pituitary–adrenal axis in women with chronic pelvic pain. Psychosom Med. 1998;60:309–318
  55. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35
  56. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, et al. Pituitary–adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000;284:592–597
  57. Heim C, Mletzko T, Purselle D, Musselman DL, Nemeroff CB. The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol. Psychiatry. 2008;63:398–405
  58. Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am. J. Psychiatry. 2001;158:575–581
  59. Heim C, Newport DJ, Wagner D, Wilcox MM, Miller AH, Nemeroff CB. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety. 2002;15:117–125
  60. Heim C, Plotsky PM, Nemeroff CB. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology. 2004;29:641–648
  61. Heim C, Wagner D, Maloney E, Papanicolaou DA, Solomon L, Jones JF, et al. Early adverse experience and risk for chronic fatigue syndrome: a population based study. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch. Gen. Psychiatry. 2006;63:1258–1266
  62. Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatry Res. 1994;28:341–356
  63. Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Muller OA. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N. Engl. J. Med. 1984;311:1127
  64. Holsboer F, Lauer CJ, Schreiber W, Krieg JC. Altered hypothalamic–pituitary–adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology. 1995;62:340–347
  65. Huot RL, Plotsky PM, Lenox RH, McNamara RK. Neonatal maternal separation reduces hippocampal mossy fiber density in adult Long Evans rats. Brain Res. 2002;950:52–63
  66. Imbierowicz K, Egle UT. Childhood adversities in patients with fibromyalgia and somatoform pain disorder. Eur. J. Pain. 2003;7:113–119
  67. Ising M, Kunzel HE, Binder EB, Nickel T, Modell S, Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;29:1085–1093
  68. Kaplan MJ, Klinetob NA. Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression. J. Nerv. Ment. Dis. 2000;188:596–601
  69. Kaufman J, Birmaher B, Perel J, Dahl RE, Moreci P, Nelson B, et al. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Biol. Psychiatry. 1997;42:669–679
  70. Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc. Natl. Acad. Sci. USA. 2004;101:17316–17721
  71. Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry. 2006;59:673–680
  72. Keightley ML, Seminowicz DA, Bagby RM, Costa PT, Fossati P, Mayberg HS. Personality influences limbic–cortical interactions during sad mood induction. Neuroimage. 2003;20:2031–2039
  73. Kendler KS, Kessler RC, Neale MC, Heath AC, Eaves LJ. The prediction of major depression in women: toward an integrated etiologic model. Am. J. Psychiatry. 1993;150:1139–1148
  74. Kendler KS, Bulik CM, Silberg J, Hettema JM, Myers J, Prescott CA. Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis. Arch. Gen. Psychiatry. 2000;57:953–959
  75. Kendler KS, Kuhn JW, Prescott CA. Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol. Med. 2004;34:1475–1482
  76. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch. Gen. Psychiatry. 2005;62:529–535
  77. Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry. 2006;[Epub ahead of print]
  78. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 2000;342:1462–1470
  79. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005;25:11489–11493
  80. Kirschbaum C, Pirke KM, Hellhammer DH. The ‘Trier Social Stress Test’—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28:76–81
  81. Kirschbaum C, Schommer N, Federenko I, Gaab J, Neumann O, Oellers M, et al. Short-term estradiol treatment enhances pituitary–adrenal axis and sympathetic responses to psychosocial stress in healthy young men. J. Clin. Endocrinol. Metab. 1996;81:3639–3643
  82. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005;435:673–676
  83. Kruger S, Seminowicz D, Goldapple K, Kennedy SH, Mayberg HS. State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol. Psychiatry. 2003;54:1274–1283
  84. Kruger S, Alda M, Young LT, Goldapple K, Parikh S, Mayberg HS. Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am. J. Psychiatry. 2006;163:257–264
  85. Kudielka BM, Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005;69:113–132
  86. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog. Brain Res. 2000;122:81–103
  87. Lara ME, Klein DN, Kasch KL. Psychosocial predictors of the short-term course and outcome of major depression: a longitudinal study of a nonclinical sample with recent-onset episodes. J. Abnorm. Psychol. 2000;109:644–650
  88. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–1531
  89. MacMillan HL, Fleming JE, Streiner DL, Lin E, Boyle MH, Jamieson E, et al. Childhood abuse and lifetime psychopathology in a community sample. Am. J. Psychiatry. 2001;158:1878–1883
  90. Maercker A, Michael T, Fehm L, Becker ES, Margraf J. Age of traumatisation as a predictor of post-traumatic stress disorder or major depression in young women. Br. J. Psychiatry. 2004;184:482–487
  91. Mayberg HS. Modulating dysfunctional limbic–cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 2003;65:193–207
  92. McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, DeChant HK, et al. Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA. 1997;277:1362–1368
  93. McEwen BS. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 2001;91:2785–2801
  94. McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. NY Acad. Sci. 2004;1032:1–7
  95. Meaney MJ, Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin. Neurosci. 2005;7:103–123
  96. Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, et al. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry. 2006;59:594–602
  97. Mirescu C, Peters JD, Gould E. Early life experience alters response of adult neurogenesis to stress. Nat. Neurosci. 2004;7:841–846
  98. Modell S, Lauer CJ, Schreiber W, Huber J, Krieg JC, Holsboer F. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology. 1998;18:253–262
  99. Molnar BE, Buka SL, Kessler RC. Child sexual abuse and subsequent psychopathology: results from the National Comorbidity Survey. Am. J. Public Health. 2001;91:753–760
  100. Mullen PE, Martin JL, Anderson JC, Romans SE, Herbison GP. The long-term impact of the physical, emotional, and sexual abuse of children: a community study. Child Abuse Negl. 1996;20:7–21
  101. Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol. Psychiatry. 2007;Oct 17 [Epub ahead of print]
  102. Nelson EC, Heath AC, Madden PA, Cooper ML, Dinwiddie SH, Bucholz KK, et al. Association between self-reported childhood sexual abuse and adverse psychosocial outcomes: results from a twin study. Arch. Gen. Psychiatry. 2002;59:139–145
  103. Nemeroff CB, Widerlöv E, Bissette G, Walleus H, Karlsson I, Eklund K, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984;226:1342–1344
  104. Nemeroff CB, Heim C, Thase ME, Rush AJ, Schatzberg AF, Ninan PT, et al. Differential responses to psychotherapy versus pharmacotherapy in the treatment of patients with chronic forms of major depression and childhood trauma. Proc. Nat. Acad. Sci. USA. 2003;100:14293–14296
  105. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13–25
  106. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M, et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch. Gen. Psychiatry. 2002;59:613–620
  107. Neumeister A, Wood S, Bonne O, Nugent AC, Luckenbaugh DA, Young T, et al. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol. Psychiatry. 2005;57:935–937
  108. Newport DJ, Heim C, Bonsall R, Miller AH, Nemeroff CB. Pituitary–adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol. Psychiatry. 2004;55:10–20
  109. Oquendo MA, Echavarria G, Galfalvy HC, Grunebaum MF, Burke A, Barrera A, et al. Lower cortisol levels in depressed patients with comorbid post-traumatic stress disorder. Neuropsychopharmacology. 2003;28:591–598
  110. Pace TWW, Mletzko T, Alagbe O, Nemeroff CB, Musselman DL, Miller AH, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry. 2006;163:1630–1633
  111. Pariante CM. Glucocorticoid receptor function in vitro in patients with major depression. Stress. 2004;7:209–219
  112. Parker G. Classifying depression: should paradigms lost be regained?. Am. J. Psychiatry. 2000;157:1195–1203
  113. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, et al. 5-HTTLPR polymorphism impacts human cingulated–amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005;8:828–834
  114. Plotsky PM, Sánchez MM, Levine S. Intrinsic and extrinsic factors modulating physiological coping systems during development. In:  Broom DM editors. Coping with Challenge. Berlin: Dahlem University Press; 2001;p. 169–196
  115. Plotsky PM, Thrivikraman KV, Nemeroff CB, Caldji C, Sharma S, Meaney MJ. Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology. 2005;30:2192–2204
  116. Pollak SD, Kistler DJ. Early experience is associated with the development of categorical representations for facial expressions of emotion. Proc. Natl. Acad. Sci. USA. 2002;99:9072–9076
  117. Posener JA, DeBattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF. 24-h monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch. Gen. Psychiatry. 2000;57:755–760
  118. Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J. Neurosci. 2004;24:2825–2831
  119. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994;60:436–444
  120. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry. 1995;152:1372–1376
  121. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry. 2003;160:1554–1565
  122. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31
  123. Rhodes ME, Rubin RT. Functional sex differences (‘sexual diergism’) of central nervous system cholinergic systems, vasopressin, and hypothalamic–pituitary–adrenal axis activity in mammals: a selective review. Brain Res. Brain Res. Rev. 1999;30:135–152
  124. Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W. Hyperresponsiveness of hypothalamic–pituitary–adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol. Psychiatry. 2002;52:1102–1112
  125. Roca CA, Schmidt PJ, Deuster PA, Danaceau MA, Altemus M, Putnam K, et al. Sex-related differences in stimulated hypothalamic–pituitary–adrenal axis during induced gonadal suppression. J. Clin. Endo. Metab. 2005;90:4224–4231
  126. Rusch BD, Abercrombie HC, Oakes TR, Schaefer SM, Davidson RJ. Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Biol. Psychiatry. 2001;50:960–964
  127. Sánchez MM, Ladd CO, Plotsky PM. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev. Psychopathol. 2001;13:419–449
  128. Sánchez MM, Noble PM, Lyon CK, Plotsky PM, Davis M, Nemeroff CB, et al. Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol. Psychiatry. 2005;57:373–381
  129. Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, et al. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch. Gen. Psychiatry. 2005;62:513–520
  130. Schienle A, Schafer A, Stark R, Walter B, Vaitl D. Gender differences in the processing of disgust- and fear-inducing pictures: an fMRI study. Neuroreport. 2005;16:277–280
  131. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, et al. Limbic–rontal circuitry in major depression: a path modeling metanalysis. Neuroimage. 2004;22:409–418
  132. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA. 1996;93:3908–3913
  133. Smith LJ, Henderson JA, Abell CW, Bethea CL. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology. 2004;29:2035–2045
  134. Stein MB, Koverola C, Hanna C, Torchia MG, McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol. Med. 1997;27:951–959
  135. Swanson LW, Simmons DM. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 1989;285:413–435
  136. Taylor SE, Eisenberger NI, Saxbe D, Lehman BJ, Lieberman MD. Neural responses to emotional stimuli are associated with childhood family stress. Biol. Psychiatry. 2006;60:296–301
  137. Teicher MH, Anderson SL, Polcari A, Anderson CM, Navalta CP, Kim DM. The neurobiological consequences of early stress and child maltreatment. Neurosci. Biobehav. Rev. 2003;27:33–44
  138. Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol. Psychiatry. 2000;47:1087–1090
  139. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. J. Clin. Invest. 1993;92:1896–1902
  140. van Dijken HH, de Goeij DC, Sutanto W, Mos J, de Kloet ER, Tilders FJ. Short inescapable stress produces long-lasting changes in the brain–pituitary–adrenal axis of adult male rats. Neuroendocrinology. 1993;58:57–64
  141. Vythilingam M, Heim C, Newport DJ, Miller AH, Vermetten E, Anderson E, et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am. J. Psychiatry. 2002;159:2072–2080
  142. Wang J, Rao H, Wetmore GS, Furlan PM, Korczykowski M, Dinges DF, et al. Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress. Proc. Natl. Acad. Sci. USA. 2005;102:17804–17809
  143. Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004;7:847–854
  144. Weiss EL, Longhurst JG, Mazure CM. Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates. Am. J. Psychiatry. 1999;156:816–828
  145. Widerlöv E, Bissette G, Nemeroff CB. Monoamine metabolites, corticotropin-releasing factor and somatostatin as CSF markers in depresssed patients. J. Affect. Dis. 1988;14:99–107
  146. Williams LM, Barton MJ, Kemp AH, Liddell BJ, Peduto A, Gordon E, et al. Distinct amygdale–autonomic arousal profiles in response to fear signals in healthy males and females. Neuroimage. 2005;28:618–626
  147. Wilson M. DSM-III and the transformation of American psychiatry: a history. Am. J. Psychiatry. 1993;150:399–410
  148. Winslow JT, Noble PL, Lyons CK, Sterk SM, Insel TR. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology. 2003;28:910–918
  149. Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann. NY Acad. Sci. 2006;1071:137–166
  150. Young EA. Sex differences and the HPA axis: implications for psychiatric disease. J. Gend. Specif. Med. 1998;1:21–27
  151. Young EA, Abelson JL, Cameron OG. Effect of comorbid anxiety disorders on the hypothalamic–pituitary–adrenal axis response to a social stressor in major depression. Biol. Psychiatry. 1994;56:113–120
  152. Young EA, Abelson JL, Curtis GC, Nesse RM. Childhood adversity and vulnerability to mood and anxiety disorders. Depress Anxiety. 1997;5:66–72
  153. Young LJ, Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 2004;7:1048–1054
  154. Zald DH, Mattson DL, Pardo JV. Brain activity in ventromedial prefrontal cortex correlates with individual differences in negative affect. Proc. Natl. Acad. Sci. USA. 2002;99:2450–2454
  155. Zlotnick C, Ryan CE, Miller IW, Keitner GI. Childhood abuse and recovery from major depression. Child Abuse Negl. 1995;19:1513–1516
  156. Zlotnick C, Mattia J, Zimmerman M. Clinical features of survivors of sexual abuse with major depression. Child Abuse Negl. 2001;25:357–367

PII: S0306-4530(08)00069-3

doi: 10.1016/j.psyneuen.2008.03.008

Psychoneuroendocrinology
Volume 33, Issue 6 , Pages 693-710 , July 2008